GO:0004311 geranylgeranyl diphosphate synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004311 describes the catalytic activity that converts farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP) into geranylgeranyl diphosphate (GGPP), a key branch point in the mevalonate pathway.
• GGDPS enzymes are conserved across insects, plants, and mammals, and their catalytic efficiency can be enhanced by ancestral sequence reconstruction and semirational design.
• GGPP produced by this activity is essential for protein geranylgeranylation, which regulates small GTPases such as Rho, Rac, and Rab.
• Dysregulated GGDPS activity is implicated in cancers including osteosarcoma, Ewing sarcoma, and lung fibrosis, making it a therapeutic target.
• Innate immune signaling and inflammasome activation are modulated by GGDPS activity, linking this enzyme to sepsis and acute lung injury.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of GGDPS function in health and disease.
Description
Geranylgeranyl diphosphate synthase (GGDPS) activity, encoded by GO:0004311, catalyzes the condensation of farnesyl diphosphate (FPP) with isopentenyl diphosphate (IPP) to produce geranylgeranyl diphosphate (GGPP). This reaction represents a critical node in the mevalonate pathway, directing carbon flux toward the synthesis of geranylgeranylated proteins, carotenoids, chlorophylls, and other isoprenoids. Because GGPP serves as the lipid donor for geranylgeranylation of small GTPases, GGDPS activity influences diverse cellular processes including membrane trafficking, cell proliferation, and immune signaling. Researchers study GO:0004311 to understand how isoprenoid biosynthesis is regulated and to develop inhibitors or genetic tools that modulate this pathway in cancer, fibrosis, and infectious disease models. The enzyme has been characterized biochemically and structurally across species, revealing conserved aspartate-rich motifs and a two-step catalytic mechanism. Recent work has also explored ancestral sequence reconstruction to improve catalytic activity, highlighting the evolutionary plasticity of this enzyme.
geranylgeranyl diphosphate synthase activity At A Glance
| GO ID | GO:0004311 |
|---|---|
| GO term | geranylgeranyl diphosphate synthase activity |
| Ontology | molecular_function |
| Synonym | farnesyltranstransferase activity; geranylgeranyl-diphosphate synthase activity; geranylgeranyl-PP synthetase activity; geranylgeranyl pyrophosphate synthase activity; geranylgeranyl pyrophosphate synthetase activity; trans,trans-farnesyl-diphosphate:isopentenyl-diphosphate farnesyltranstransferase activity |
| Definition | Catalysis of the reaction: (2E,6E)-farnesyl diphosphate + isopentenyl diphosphate = (2E,6E,10E)-geranylgeranyl diphosphate + diphosphate |
| Major function | Production of geranylgeranyl diphosphate for protein geranylgeranylation and isoprenoid biosynthesis |
| Substrates | Farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP) |
| Products | Geranylgeranyl diphosphate (GGPP) and diphosphate |
| Cofactors | Divalent metal ions such as Mg2+ or Mn2+ |
| Pathway | Mevalonate pathway / isoprenoid biosynthesis |
What Is GO:0004311?
GO:0004311, geranylgeranyl diphosphate synthase activity, is defined as the catalysis of the reaction: (2E,6E)-farnesyl diphosphate + isopentenyl diphosphate = (2E,6E,10E)-geranylgeranyl diphosphate + diphosphate. In simpler terms, this activity adds one five-carbon isopentenyl unit to farnesyl diphosphate to form the twenty-carbon geranylgeranyl diphosphate. The reaction is a trans-condensation that proceeds through a carbocation intermediate and requires divalent metal ions such as Mg2+ or Mn2+ for catalysis. This activity is synonymous with farnesyltranstransferase, geranylgeranyl-diphosphate synthase, and geranylgeranyl pyrophosphate synthetase.
Why Is geranylgeranyl diphosphate synthase activity Important in Cell Biology?
GO:0004311 is important because the GGPP it produces is a central metabolite that feeds into multiple essential pathways, including protein geranylgeranylation, which is required for the membrane localization and function of small GTPases such as Rho, Rac, and Rab. Dysregulation of GGDPS activity has been linked to cancer progression, lung fibrosis, and inflammatory diseases, making it a promising target for therapeutic intervention. In insects, GGDPS is being explored as a pesticide target due to its role in juvenile hormone biosynthesis and development. Understanding this activity at the molecular level enables the design of specific inhibitors and the development of CRISPR models to study its physiological roles.
• GGDPS activity is a key branch point in the mevalonate pathway, directing flux toward GGPP and geranylgeranylated proteins.
• GGPP is essential for the geranylgeranylation of small GTPases, which regulate cell growth, cytoskeletal dynamics, and vesicle trafficking.
• Inhibition of GGDPS activity is being investigated as a therapeutic strategy for osteosarcoma and Ewing sarcoma.
• GGDPS deficiency aggravates lung fibrosis by modulating TGF-β1/BMP-4 signaling, highlighting its role in tissue remodeling.
• Knockdown of GGDPS1 suppresses NLRP3 inflammasome activity via autophagy in sepsis-induced acute lung injury.
• ENKD1 modulates innate immune responses through enhanced geranylgeranyl pyrophosphate synthase activity.
• Lepidopteran and sandfly GGDPS enzymes are potential targets for insect control.
• Ancestral sequence reconstruction has been used to enhance the catalytic activity of GGDPS, demonstrating its engineering potential.
• Structural insights into GGDPS provide a framework for designing cancer therapeutics.
• CRISPR-based models allow precise manipulation of GGDPS genes to study their roles in disease and development.
What Happens During geranylgeranyl diphosphate synthase activity?
Substrate Binding and Metal Coordination
In simple terms: The enzyme grabs its two substrates and holds them in place with the help of metal ions.
GGDPS binds farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP) in its active site, which contains conserved aspartate-rich motifs that coordinate divalent metal ions such as Mg2+ or Mn2+. These metal ions stabilize the diphosphate groups of the substrates and facilitate the subsequent condensation reaction.
Condensation and Carbocation Formation
In simple terms: The enzyme joins the two molecules together by creating a reactive intermediate.
The catalytic mechanism involves the ionization of FPP to form a farnesyl carbocation, which then attacks the double bond of IPP in a trans-addition manner. This step is highly stereospecific, yielding the (2E,6E,10E)-geranylgeranyl diphosphate product.
Product Release and Pathway Integration
In simple terms: The finished GGPP molecule is released and used elsewhere in the cell.
After the condensation, GGPP is released from the active site and becomes available for protein geranylgeranylation, carotenoid biosynthesis, or other isoprenoid pathways. The activity of GGDPS thus determines the flux of carbon into these downstream processes.
Regulation by Cellular Demand
In simple terms: The cell adjusts how much GGPP it makes based on its needs.
GGDPS activity can be regulated at the transcriptional level and by feedback from downstream metabolites. In immune cells, ENKD1 enhances GGDPS activity to modulate innate immune responses, illustrating context-dependent regulation. In sepsis-induced acute lung injury, GGDPS1 knockdown promotes autophagy and suppresses NLRP3 inflammasome activity.
Key Genes Involved in GO:0004311 geranylgeranyl diphosphate synthase activity
The following genes and proteins are directly involved in or regulate geranylgeranyl diphosphate synthase activity (GO:0004311) and its downstream pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GGPS1 | Encodes geranylgeranyl diphosphate synthase in humans | Target for cancer therapy and fibrosis studies |
| GGPS1 (Lutzomyia longipalpis) | GGDPS enzyme in sandfly | Characterized for insect control |
| GGPS1 (Lepidoptera) | GGDPS enzyme in moths | Putative pesticide target |
| ENKD1 | Enhances GGDPS activity | Modulates innate immune responses |
| RhoA | Small GTPase geranylgeranylated by GGPP | Regulates cytoskeleton and proliferation |
| Rac1 | Small GTPase geranylgeranylated by GGPP | Involved in cell migration and immune signaling |
| Rab proteins | Small GTPases requiring geranylgeranylation | Regulate vesicle trafficking |
| TGF-β1 | Signaling molecule modulated by GGDPS deficiency | Linked to lung fibrosis |
| BMP-4 | Signaling molecule modulated by GGDPS deficiency | Linked to lung fibrosis |
| NLRP3 | Inflammasome component suppressed by GGDPS1 knockdown | Sepsis-induced acute lung injury |
| FDPS | Farnesyl diphosphate synthase, upstream of GGDPS | Provides FPP substrate |
| HMGCR | Rate-limiting enzyme in mevalonate pathway | Upstream regulator of GGDPS substrate supply |
| Caspase-1 | Downstream of NLRP3 inflammasome | Affected by GGDPS1 knockdown |
| LC3 | Autophagy marker | Increased upon GGDPS1 knockdown |
| SQSTM1/p62 | Autophagy receptor | Modulated by GGDPS1 knockdown |
| GGPS1 (ancestral) | Reconstructed ancestral GGDPS variants | Enhanced catalytic activity |
| GGDPS (structural) | Structural models for inhibitor design | Cancer therapy development |
How Is geranylgeranyl diphosphate synthase activity Regulated?
GGDPS activity is regulated at multiple levels. Transcriptionally, the GGPS1 gene can be induced by growth factors and cytokines, while feedback inhibition by downstream isoprenoids may modulate enzyme levels. In immune cells, ENKD1 enhances GGDPS activity to promote innate immune responses, demonstrating post-translational or interacting-partner regulation. In sepsis-induced acute lung injury, GGDPS1 knockdown promotes autophagy and suppresses NLRP3 inflammasome activity, indicating that GGDPS activity influences inflammatory signaling pathways. Additionally, the mevalonate pathway upstream of GGDPS is tightly controlled by HMGCR, which affects substrate availability for GGPP synthesis.
geranylgeranyl diphosphate synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GGPS1 | Osteosarcoma and Ewing sarcoma | Knockout and overexpression in sarcoma cell lines |
| GGPS1 | Lung fibrosis | Knockout mice and TGF-β1/BMP-4 signaling assays |
| GGPS1 | Sepsis-induced acute lung injury | Knockdown in lung epithelial cells and autophagy assays |
| ENKD1 | Innate immune responses | Overexpression and knockout in immune cells |
| GGPS1 | Insect development (pesticide target) | Knockdown in lepidopteran and sandfly models |
Cancer
GGDPS activity is upregulated in several cancers, including osteosarcoma and Ewing sarcoma, where it supports the geranylgeranylation of oncogenic small GTPases. Inhibition of GGDPS reduces tumor cell proliferation and survival, making it a promising therapeutic target. Structural studies have provided a basis for designing specific GGDPS inhibitors for cancer therapy.
Lung Fibrosis
GGDPS deficiency aggravates lung fibrosis in mice by modulating TGF-β1/BMP-4 signaling. This suggests that GGDPS activity plays a protective role in lung tissue homeostasis, and its dysregulation may contribute to fibrotic disease progression.
Sepsis and Acute Lung Injury
Knockdown of GGDPS1 suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury. This links GGDPS activity to inflammatory pathways and suggests that modulating GGDPS could be a strategy for treating sepsis-associated lung injury.
Innate Immunity
ENKD1 modulates innate immune responses through enhanced geranylgeranyl pyrophosphate synthase activity. This indicates that GGDPS activity is directly involved in immune signaling, potentially affecting host defense and inflammatory diseases.
From geranylgeranyl diphosphate synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GGDPS loss affect cancer cell proliferation? | CRISPR knockout of GGPS1 in osteosarcoma cell lines |
| How does GGDPS deficiency alter lung fibrosis? | GGPS1 knockout mice treated with bleomycin |
| Does GGDPS1 knockdown affect inflammasome activity? | CRISPR interference or knockout in lung epithelial cells |
| Can GGDPS activity be enhanced for biotechnology? | Point mutations or ancestral reconstruction in GGPS1 |
| How does ENKD1 regulate GGDPS activity? | Knock-in of tagged ENKD1 and co-immunoprecipitation |
| Is GGDPS a viable pesticide target? | RNAi knockdown in lepidopteran larvae |
How to Study the geranylgeranyl diphosphate synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | GGDPS catalytic activity | Characterization of wild-type and mutant enzymes |
| X-ray crystallography | Three-dimensional structure | Inhibitor design and mechanism |
| CRISPR knockout | Gene function loss | Cancer and fibrosis models |
| RNA-seq | Transcriptional changes | Pathway analysis after GGPS1 manipulation |
| Proteomics | Protein expression and modifications | Geranylgeranylation status |
| Autophagy flux assay | Autophagic activity | Sepsis-induced lung injury models |
| Inflammasome activation assay | NLRP3 activity | Innate immunity studies |
| Insect bioassay | Larval development and mortality | Pesticide target validation |
Enzymatic Activity Assays
GGDPS activity can be measured using radiometric or fluorometric assays that monitor the conversion of FPP and IPP to GGPP. These assays are typically performed with recombinant enzyme and require divalent metal ions.
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the structure of GGDPS, revealing the active site and substrate binding pockets. These structures guide inhibitor design and mechanistic studies.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate GGDPS activity or sensitivity to GGDPS inhibitors. Such screens help uncover synthetic lethal interactions and resistance mechanisms.
RNA-seq and Proteomics
Transcriptomic and proteomic profiling of cells with GGPS1 knockout or overexpression reveals downstream changes in geranylgeranylated proteins and signaling pathways. These methods help link GGDPS activity to cellular phenotypes.
How CRISPR Can Be Used to Study GO:0004311 geranylgeranyl diphosphate synthase activity
Knockout
CRISPR knockout of GGPS1 eliminates GGDPS activity, allowing researchers to study its essential roles in cell proliferation, protein geranylgeranylation, and disease progression. Knockout models have been used to demonstrate that GGDPS deficiency aggravates lung fibrosis and suppresses tumor growth.
Point Mutation
Point mutations in the GGPS1 active site can be introduced to dissect catalytic residues and metal-coordinating motifs. Such mutants help confirm the mechanism of substrate binding and condensation.
Knock-in
Knock-in of tagged GGPS1 or reporter constructs enables real-time monitoring of GGDPS expression and localization. This approach is useful for studying regulation by interacting proteins such as ENKD1.
Overexpression
Overexpression of wild-type or enhanced GGPS1 variants increases GGPP production and can be used to study downstream effects on geranylgeranylation and cell signaling. Ancestral sequence reconstruction has yielded variants with improved catalytic activity for biotechnological applications.
How EDITGENE Supports geranylgeranyl diphosphate synthase activity Research
Researchers studying geranylgeranyl diphosphate synthase activity-related genes often need to determine whether a candidate gene is causally involved in GGPP production, protein geranylgeranylation, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation of GGPS1 and related pathway genes.
Contact EDITGENE today to design your custom CRISPR model for geranylgeranyl diphosphate synthase activity research.
Frequently Asked Questions About geranylgeranyl diphosphate synthase activity
What is geranylgeranyl diphosphate synthase activity?
It is the enzymatic activity (GO:0004311) that catalyzes the conversion of farnesyl diphosphate and isopentenyl diphosphate to geranylgeranyl diphosphate, a key molecule in the mevalonate pathway.
What genes are involved in geranylgeranyl diphosphate synthase activity?
The primary gene is GGPS1, which encodes the enzyme. Other genes such as ENKD1 regulate its activity, and downstream targets include Rho, Rac, and Rab GTPases.
What diseases are associated with geranylgeranyl diphosphate synthase activity?
Dysregulation is linked to cancers like osteosarcoma and Ewing sarcoma, lung fibrosis, sepsis-induced acute lung injury, and innate immune disorders.
How is geranylgeranyl diphosphate synthase activity regulated?
It is regulated transcriptionally, by feedback from downstream metabolites, and through interacting proteins such as ENKD1.
What is the role of GGPP in cells?
GGPP serves as a lipid donor for geranylgeranylation of small GTPases, which is essential for their membrane localization and function in cell growth, trafficking, and signaling.
Can geranylgeranyl diphosphate synthase be targeted for cancer therapy?
Yes, inhibitors of GGDPS are being developed as anticancer agents, particularly for osteosarcoma and Ewing sarcoma.
What model systems are used to study GGDPS?
Common models include CRISPR knockout cell lines, mouse models of fibrosis and cancer, and insect models for pesticide development.
How can I measure geranylgeranyl diphosphate synthase activity?
Enzymatic assays using recombinant enzyme and radiolabeled substrates are standard, along with structural and computational methods.
Is GGDPS a potential pesticide target?
Yes, studies in sandflies and lepidopteran insects suggest that GGDPS is a promising target for insect control.
What CRISPR services are available for GGDPS research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to GGPS1 and related genes.
Conclusion
Geranylgeranyl diphosphate synthase activity (GO:0004311) is a critical enzymatic step in the mevalonate pathway, supplying GGPP for protein geranylgeranylation and diverse isoprenoid products. Its roles in cancer, fibrosis, immunity, and insect development make it a compelling target for both therapeutic and biotechnological applications. Advances in structural biology, ancestral reconstruction, and CRISPR-based models continue to deepen our understanding of this enzyme and its regulation. Targeting GGDPS with precision genetic tools holds promise for developing new treatments for diseases driven by dysregulated isoprenoid metabolism.
References
- 1. Wang Z et al.. 2024. Enhancing the Catalytic Activity of Geranylgeranyl Diphosphate Synthase through Ancestral Sequence Reconstruction and Semirational Design.. J Agric Food Chem 72(34):19187-19196 PMID: 39137390
- 2. Ducker C et al.. 2023. Characterisation of geranylgeranyl diphosphate synthase from the sandfly Lutzomyia longipalpis.. Insect Biochem Mol Biol 161:104001 PMID: 37619821
- 3. Pham AC et al.. 2024. Structural Insight into Geranylgeranyl Diphosphate Synthase (GGDPS) for Cancer Therapy.. Mol Cancer Ther 23(1):14-23 PMID: 37756579
- 4. Katsavou E et al.. 2024. Characterisation of lepidopteran geranylgeranyl diphosphate synthase as a putative pesticide target.. Insect Mol Biol 33(2):147-156 PMID: 37962063
- 5. Zhang T et al.. 2025. ENKD1 modulates innate immune responses through enhanced geranylgeranyl pyrophosphate synthase activity.. Cell Rep 44(3):115397 PMID: 40048432
- 6. Chen M et al.. 2019. Geranylgeranyl diphosphate synthase deficiency aggravates lung fibrosis in mice by modulating TGF-β1/BMP-4 signaling.. Biol Chem 400(12):1617-1627 PMID: 31120854
- 7. Li D et al.. 2021. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.. Int Immunopharmacol 100:108106 PMID: 34530204
- 8. Haney SL et al.. 2023. Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma.. Drug Dev Res 84(1):62-74 PMID: 36433690
